Skip to content
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Growing a new brain with 3-D technology

Scientists in Singapore have grown a tiny version of a portion of the human brain.

These “organoids,” grown from human tissue and small enough to fit several on a fingernail, replicate functions of the human mid-brain. The mid-brain is an information-transfer hub that controls the senses, physical movement and produces dopamine, a key to fluid physical movements. Parkinson’s Disease is associated with low dopamine levels.

That’s the point: Scientists grew these mini-midbrains to research possible Parkinson’s treatments directly, instead of using animal brains or computer simulations to test drugs and understand how the disease originates and progresses.

Meanwhile, researchers at the Johns Hopkins School of Medicine have grown mini-forebrains to study the workings of the Zika virus on fetal development.
Growing mini-brains isn’t a new technology, but it’s been expensive due to the precise environment and nutrients required. The Hopkins group developed a new and cheaper way, thanks to three high-school summer interns who used a 3-D printer to create a more cost-effective “bioreactor” to do the job.

The pinhead-size forebrains allowed the scientists to confirm what simulations and petri-dish experiments had indicated: The Zika virus invades stem cells in the brain and, instead of allowing them to develop normally, turns them into virus factories.